NCI COVID-19 in Cancer Patients, NCCAPS Study – Full Text View – ClinicalTrials.gov
NCI COVID-19 in Cancer Patients, NCCAPS Study – Full Text View.
NCI COVID-19 in Cancer Patients, NCCAPS Study – Full Text View.
PURPOSE This review summarizes the published evidence on the clinical impact of using next-generation sequencing (NGS) tests to guide management of patients with cancer in…
This case report illustrates the need for real-time integration of proteogenomic data from laser microdissected tumor specimens and dynamic biopsy testing
Comprehensive genomic profiling (CGP) uses next-generation sequencing methods to detect specific molecular abnormalities in a patient’s tumor. CGP can disclose biomarkers at nucleotide-level resolution and…
PURPOSE Clinical trials of novel and targeted agents increasingly require biomarkers for eligibility. Precision oncology continues to evolve, but challenges hamper broad use of molecular…
PURPOSE Many patients with actionable driver oncogenes (ADOs) are never identified and thus never receive targeted treatment. This study evaluated the economic impact and the…
Abstract. The Veterans Health Administration is the largest integrated provider of cancer services in the nation, with approximately 50,000 new cancer cases dia
AbstractUsing 48,627 samples from the Center for Cancer Genomics and Advanced Therapeutics (C-CAT), we present a pan-cancer landscape of driver alterations and their clinical actionability…
Program: Oral and Poster Abstracts Session: 731. Clinical Autologous Transplantation: Results: Poster I Hematology Disease Topics & Pathways: Adult, Non-Biological, Therapies, Study Population, Clinically relevant…
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.